Limits of Patentability [electronic resource] :Plant Sciences, Stem Cells and Nucleic Acids / by Andreas Hübel, Ulrich Storz, Aloys Hüttermann.
by Hübel, Andreas [author.]; Storz, Ulrich [author.]; Hüttermann, Aloys [author.]; SpringerLink (Online service).
Material type:
BookSeries: SpringerBriefs in Biotech Patents: Publisher: Berlin, Heidelberg : Springer Berlin Heidelberg : 2013.Description: VIII, 46 p. 2 illus. online resource.ISBN: 9783642328411.Subject(s): Life sciences | Medical genetics | Genetic engineering | Nucleic acids | Stem cells | Plant breeding | Commercial law | Life Sciences | Stem Cells | Gene Function | Plant Breeding/Biotechnology | Nucleic Acid Chemistry | Genetic Engineering | Commercial LawDDC classification: 571.6 Online resources: Click here to access online | Item type | Current location | Call number | Status | Date due | Barcode |
|---|---|---|---|---|---|
| MAIN LIBRARY | QH588.S83 (Browse shelf) | Available |
Browsing MAIN LIBRARY Shelves Close shelf browser
| QH588.S83 Regenerative Medicine and Cell Therapy | QH588.S83 Mitochondrial DNA, Mitochondria, Disease and Stem Cells | QH588.S83 Mesenchymal Stem Cell Therapy | QH588.S83 Limits of Patentability | QH588.S83 Jak-Stat Signaling : From Basics to Disease | QH588.S83 Perspectives of Stem Cells | QH588.S83 Induced Pluripotent Stem Cells in Brain Diseases |
Preface -- Andreas Hübel: The Boundaries of Limits - Plant Biosciences -- Ulrich Storz: The Limits of Patentability - Stem Cells -- Aloys Hüttermann: The LImits of Patentability - Genes and Nucleic Acids -- About the Authors.
SpringerBriefs in Biotech Patents presents timely reports on intellectual properties (IP) issues and patent aspects in the field of biotechnology. In this volume the limits of patentability are addressed, a question that is often raised when it comes to biotechnological inventions: The first section addresses current issues in the patentability of plants produced by essentially biological processes including the controversy between farmer’s privilege and patent exhaustion with respect to seeds in the US. The second section examines the patentability of human embryonic stem cells in Europe and the US, also considering alternative technologies with respect to their practicability and patentability. The third section focuses on the patentability of genes and nucleic acids, especially the issue of patenting of encoding genes and nucleic acids.
There are no comments for this item.